Form EFFECT Processa Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 23, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Latest Data of Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2026
- CVR Partners Announces Revised Time for Third Quarter 2026 Earnings Conference Call
- Strategic Resources Inc. Sets AGM Date and a Member of the Board of Directors Resigns
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share